Home Cart 0 Sign in  
X

[ CAS No. 130473-26-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 130473-26-6
Chemical Structure| 130473-26-6
Chemical Structure| 130473-26-6
Structure of 130473-26-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 130473-26-6 ]

Related Doc. of [ 130473-26-6 ]

Alternatived Products of [ 130473-26-6 ]

Product Details of [ 130473-26-6 ]

CAS No. :130473-26-6 MDL No. :MFCD10697530
Formula : C8H6N2O Boiling Point : -
Linear Structure Formula :- InChI Key :SHTJIHCOCNIHLP-UHFFFAOYSA-N
M.W : 146.15 Pubchem ID :14644283
Synonyms :

Calculated chemistry of [ 130473-26-6 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.48
TPSA : 45.75 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.64
Log Po/w (XLOGP3) : 0.77
Log Po/w (WLOGP) : 1.38
Log Po/w (MLOGP) : -0.32
Log Po/w (SILICOS-IT) : 2.17
Consensus Log Po/w : 0.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.77
Solubility : 2.48 mg/ml ; 0.017 mol/l
Class : Very soluble
Log S (Ali) : -1.31
Solubility : 7.14 mg/ml ; 0.0489 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.213 mg/ml ; 0.00146 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.36

Safety of [ 130473-26-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 130473-26-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 130473-26-6 ]
  • Downstream synthetic route of [ 130473-26-6 ]

[ 130473-26-6 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 130473-24-4 ]
  • [ 130473-26-6 ]
YieldReaction ConditionsOperation in experiment
81% With water; toluene-4-sulfonic acid In acetonitrile for 5 h; Heating / reflux C173 (800 mg, 4.21 mmol) is dissolved in 44 mL 10percent aqueous acetonitrile. p-Toluene sulfonic acid (630 mg, 3.3 mmol) is added, and the mixture is heated to reflux for 5 h. The mixture is cooled to rt, is concentrated in vacuo, and the resultant residue is diluted with 15 mL saturated NaHCO3. A pale yellow solid is collected, washed with water, and is dried to afford 1H-PYRROLO [2,3-c] PYRIDINE-5-CARBALDEHYDE (C174) (81percent yield). HRMS (FAB) calculated for CGH6N2O+H : 147.0558, found 147.0564 (M+H) +.
81% With toluene-4-sulfonic acid In acetonitrile 5-(1,3-Dioxolan-2-yl)-1H-pyrrolo[2,3-c]pyridine (800 mg, 4.21 mmol) is dissolved in 44 ml 10percent aqueous acetonitrile in a flask.
The solution is treated with p-toluene sulfonic acid (630 mg, 3.3 mmol), and the mixture is heated to reflux for 5 h.
The mixture is cooled to rt, is concentrated in vacuo, and the resultant residue is diluted with 15 ml saturated NaHCO3.
The pale yellow solid is collected, washed with water, and is dried to give 500 mg (81percent) of 1H-pyrrolo[2,3-c]pyridine-5-carbaldehyde. HRMS (FAB) calcd for C8H6N2O+H: 147.0558, found 147.0564 (M+H)+.
Reference: [1] Tetrahedron, 1990, vol. 46, # 9, p. 3245 - 3266
[2] Patent: US2003/153595, 2003, A1,
[3] Patent: US2003/45540, 2003, A1,
[4] Patent: WO2004/39815, 2004, A2, . Location in patent: Page 58
[5] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
[6] Patent: US2003/105089, 2003, A1,
  • 2
  • [ 119694-70-1 ]
  • [ 130473-26-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
[2] Tetrahedron, 1990, vol. 46, # 9, p. 3245 - 3266
[3] Tetrahedron, 1990, vol. 46, # 9, p. 3245 - 3266
  • 3
  • [ 108-47-4 ]
  • [ 130473-26-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
  • 4
  • [ 5832-38-2 ]
  • [ 130473-26-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
  • 5
  • [ 130473-26-6 ]
  • [ 130473-27-7 ]
YieldReaction ConditionsOperation in experiment
67% With sodium hydroxide; dihydrogen peroxide In formic acid; water C174 (500 mg, 3.42 mmol) is dissolved in 1.5 mL formic acid.
The solution is cooled in an ice bath, 30percent aqueous hydrogen peroxide (722 μL, 6.8 mmol) is added drop-wise, and the reaction is stirred 1 h in an ice bath, and allowed to stand overnight at 5° C.
The mixture is diluted with H2O, the solid is collected, washed with H2O and is dried to give 522 mg of an off-white solid.
The formate salt is added to 7 mL H2O, 3 mL 2N NaOH is added, and the pH is adjusted to 3 with 5percent aqueous HCl.
The precipitate is collected and is dried to afford 1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid (C176) (67percent yield). HRMS (FAB) calculated for C8H6N2O2+H: 163.0508, found 163.0507 (M+H).
Example 23(i)
can be obtained by coupling either exo-[2.2.1]-3-Amine or endo-[2.2.1]-3-Amine with C176.
67% With sodium hydroxide; dihydrogen peroxide In formic acid; water C174 (500 mg, 3.42 mmol) is dissolved in 1.5 mL formic acid.
The solution is cooled to in an ice bath, 30percent aqueous hydrogen peroxide (722 μL, 6.8 mmol) is added drop-wise, and the reaction is stirred 1 h in an ice bath, and allowed to stand overnight at 5° C.
The mixture is diluted with water, the solid is collected, washed with water and is dried to give 522 mg of an off-white solid.
The formate salt is added to 7 mL water, 3 mL 2N NaOH is added, and the pH is adjusted to 3 with 5percent aqueous HCl.
The precipitate is collected and is dried to afford 1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid (C176) (67percent yield). HRMS (FAB) calculated for C8H6N2O2+H: 163.0508, found 163.0507 (M+H)+.
67%
Stage #1: With dihydrogen peroxide In formic acid; water at 5℃;
Stage #2: With sodium hydroxide In water
Stage #3: With hydrogenchloride In water
C174 (500 mg, 3.42 mmol) is dissolved in 1.5 mL formic acid. The solution is cooled to in an ice bath, 30percent aqueous hydrogen peroxide (722 RL, 6.8 mmol) is added drop-wise, and the reaction is stirred 1 h in an ice bath, and allowed to stand overnight at 5C. The mixture is diluted with water, the solid is collected, washed with water and is dried to give 522 mg of an off-white solid. The formate salt is added to 7 mL water, 3 mL 2N NAOH is added, and the pH is adjusted to 3 with 5percent aqueous HC1. The precipitate is collected and is dried to afford 1H-pyrrolo [2,3-c] pyridine-5- carboxylic acid (C176 (67percent yield). HRMS (FAB) calculated for CGH6N202+H : 163.0508, found 163.0507 (M+H) +.
67% With dihydrogen peroxide In formic acid; water 1H-Pyrrolo[2,3-c]pyridine-5-carbaldehyde (500 mg, 3.42 mmol) is dissolved in 1.5 ml formic acid.
The solution is cooled in an ice bath, is treated drop-wise with 30percent aqueous hydrogen peroxide (722 μL, 6.8 mmol), is stirred 1 h in an ice bath, and allow to stand overnight at 5° C.
The mixture is diluted with water, the solid is collected, washed with water and is dried to give 522 mg of an off-white solid.
The formate salt is combined with 7 ml water, is diluted with 3 ml 2N NaOH, and the pH is adjusted to 3 with 5percent aqueous HCl.
The precipitate is collected and is dried to give 370 mg (67percent) of 1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid. HRMS (FAB) calcd for C8H6N2O2+H: 163.0508, found 163.0507 (M+H)+.

Reference: [1] Tetrahedron, 1990, vol. 46, # 9, p. 3245 - 3266
[2] Synthesis, 1993, # 3, p. 295 - 297
[3] Patent: US2003/153595, 2003, A1,
[4] Patent: US2003/45540, 2003, A1,
[5] Patent: WO2004/39815, 2004, A2, . Location in patent: Page 58
[6] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
[7] Patent: US2003/105089, 2003, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 130473-26-6 ]

Aldehydes

Chemical Structure| 25957-65-7

[ 25957-65-7 ]

1H-Pyrrolo[2,3-c]pyridine-3-carbaldehyde

Similarity: 0.81

Chemical Structure| 63875-01-4

[ 63875-01-4 ]

2-Methylisonicotinaldehyde

Similarity: 0.76

Chemical Structure| 5470-80-4

[ 5470-80-4 ]

Isoquinoline-3-carbaldehyde

Similarity: 0.75

Chemical Structure| 18206-06-9

[ 18206-06-9 ]

2,6-Dimethylisonicotinaldehyde

Similarity: 0.75

Chemical Structure| 60032-57-7

[ 60032-57-7 ]

2-Methylnicotinaldehyde

Similarity: 0.75

Related Parent Nucleus of
[ 130473-26-6 ]

Other Aromatic Heterocycles

Chemical Structure| 271-29-4

[ 271-29-4 ]

1H-Pyrrolo[2,3-c]pyridine

Similarity: 0.83

Chemical Structure| 130473-27-7

[ 130473-27-7 ]

1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid

Similarity: 0.83

Chemical Structure| 25957-65-7

[ 25957-65-7 ]

1H-Pyrrolo[2,3-c]pyridine-3-carbaldehyde

Similarity: 0.81

Chemical Structure| 244-63-3

[ 244-63-3 ]

9H-Pyrido[3,4-b]indole

Similarity: 0.77

Chemical Structure| 147071-00-9

[ 147071-00-9 ]

Methyl 1H-pyrrolo[2,3-c]pyridine-5-carboxylate

Similarity: 0.76